Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

RNomics Molecular Standards

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The NIH Common Fund, in collaboration with multiple NIH Institutes and Centers, is preparing to issue a Notice of Funding Opportunity for the RNomics Molecular Standards initiative under the broader RNomics program, which aims to advance the study of the complete RNA landscape in biological systems. This specific effort will focus on developing, testing, refining, and distributing molecular reference standards for RNA molecules, particularly those containing modified nucleosides and modified oligonucleotides, to ensure consistent, reproducible, and comparable measurements across diverse laboratories and technologies. The program will produce initial and expanded releases of these standards alongside guidance on their optimal selection and application, with plans to secure their long-term availability beyond the grant period to benefit the wider scientific community. These molecular standards are designed to serve as benchmarks for evaluating RNA sequencing, modification detection, and functional analysis tools, thereby enhancing data reliability and interoperability in RNA research. While applications are not currently being accepted, this forecast notice provides advance notice to investigators and institutions to foster collaboration, refine research proposals, and align their efforts with the program’s goals. The initiative is managed by the National Institutes of Health through the Department of Health and Human Services, with all inquiries directed to the Common Fund RNomics Program at cfrnomics@od.nih.gov. The anticipated posting date for the formal solicitation is August 5, 2026, and the program invites broad participation from the research community to ensure the standards meet diverse technical and scientific needs.

General Info

NIH to develop RNA molecular standards for reproducible, interoperable RNA research across labs and technologies.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressUS
Contacts
Common Fund RNomics Program

Full Description

Show more

The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies and resources that enable integrated analysis of RNA sequences, modifications, structures, locations, interactions, and functions to advance understanding of health and disease. RNomics includes four initiatives: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. Applications are not being solicited at this time. This notice is being provided to give potential applicants time to develop meaningful collaborations and strong projects. 

 

This NOFO will support the molecular standards initiative. Awards will support development, testing, refinement, and distribution of RNA molecular reference standards for use across the RNomics program and the broader research community. The work will include initial and expanded releases of standards for modified nucleosides and modified oligonucleotides, guidance on best practices for selecting and using standards, and planning for long-term availability beyond the funding period. These standards will support benchmarking, reproducibility, and comparison of RNA technologies across laboratories and platforms.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
International
Techno-economic Analysis for Tailings Reprocessing at Western Nuclear Abandoned Mine
Solicitation # 108-2025
The Government of Saskatchewan is seeking a qualified consultant to perform a Techno-Economic Analysis on legacy tailings from the former Western Nuclear Mine at Hanson Lake, as part of the Non-Uranium Abandoned Mines Program. The study will evaluate the mineral content of the tailings and assess the technical feasibility, economic potential, and environmental impacts of reprocessing the material for mineral recovery. This initiative serves as a pilot project designed to determine whether further phases—such as detailed engineering, pilot-scale testing, construction, operations, or site decommissioning—are warranted. The outcome will directly inform government decisions on the future management and potential reuse of the site’s residual materials. To participate in this procurement, interested suppliers must register on the Government of Saskatchewan’s Government Enterprise Management system, known as GEM, which is the sole platform for accessing competition documents, submitting questions, receiving updates, and submitting bids. The solicitation, numbered 108-2025, was posted on August 6, 2026, and responses are due by August 28, 2026. Registration is mandatory and requires completing a self-registration process via the GEM portal, where all competition-related amendments and communications will be posted. No bids will be accepted outside of this electronic system, and inquiries should be directed to the designated support email. The project is being managed by SaskBuilds and Procurement under the Saskatchewan Public Sector, with performance taking place in Saskatchewan.
SaskBuilds and Procurement

POSTED

about 6 hours ago

DEADLINE

in 23 days
View Details
NAICS: 541715
New
Federal
REQUEST FOR WHITE PAPERS BAA TOPIC: Topic 13. Biotechnology, “Controlling polymicrobial environments as a strategy for defeating harmful organisms while promoting the growth of beneficial organisms”
Solicitation # W912CG-26-S-BIOTECH
The U.S. Army Combat Capabilities Development Command Soldier Center is soliciting white papers under Broad Agency Announcement W911QY-25-R-0023 to advance biotechnological research focused on controlling polymicrobial environments to suppress harmful organisms while fostering beneficial ones, with specific emphasis on developing phage-based hygiene wipes to prevent urinary tract infections in female Warfighters. The effort aims to design, optimize, and test a cosmetic-grade formulation that maintains bacteriophage viability under extreme thermal conditions—particularly at 45°C for four weeks—while being compatible with natural cellulosic wipes, resealable packaging, and regulatory standards under the Modernization of Cosmetic Regulation Act. The proposed formulation must include a phage cocktail at a minimum titer of 1E8 PFU/ml, a neutral pH buffer, preservatives effective at pH 7–8, stabilizers like polyvinyl alcohol, and moisturizing agents, all without compromising phage activity. Up to three formulation iterations are expected, culminating in the delivery of 100 prototype wipe packs—50 with active phage and 50 without—for field-relevant testing. Submission begins with a white paper, limited to five pages, detailing the technical approach, management structure, relevant past performance, and a rough order of magnitude cost estimate covering a 12-month base period with two optional 12-month extensions. Only white papers submitted electronically by 31 August 2026, 5:00 p.m. EDT, to the designated email address will be considered eligible for further invitation to submit a full proposal. Evaluation will prioritize scientific merit, management capability, alignment with Army mission needs, and cost-effectiveness, with feedback provided to submitters. Selection of white papers does not guarantee funding or a contract award, as decisions are contingent on budget availability and program priorities. The government reserves the right to cancel the solicitation at any time without obligation. Award mechanisms may include a contract, grant, or cooperative agreement, though a contract is the intended outcome. Formal proposals will only be requested from top-scoring white papers, and no further communication with government technical personnel is permitted after submission of a full proposal.
W6QK Acc Ccdc Sttc

POSTED

about 19 hours ago

DEADLINE

in 26 days
View Details
NAICS: 541715
New
Federal
Airborne and Mobile Measurements to support NOAA ARL’s Research on Meteorology and Atmospheric Chemistry
Solicitation # 145022-26-0017
The contract solicits specialized airborne and mobile measurement services to support NOAA’s atmospheric research in key urban regions, including Washington DC/Baltimore and New York City, with additional focus on methane emissions characterization and boundary layer analysis using mobile ceilometers and drone-mounted analyzers. The contractor must provide fully equipped research aircraft, qualified flight crews, and operational support to conduct multiple research flights in compliance with FAA regulations, collecting high-quality meteorological, chemical, and navigational data that will be integrated with NOAA’s existing aircraft, satellite, and surface monitoring systems. Also required is the deployment of a mobile ceilometer for continuous planetary boundary layer height measurements and, when requested, FAA-compliant unmanned aircraft systems equipped with methane/ethane analyzers to quantify point source emissions. The effort includes analysis of mobile laboratory data collected during the 2026 SOCCER-AQ field campaign in Boston to identify and quantify urban emission sources, compare observations with emissions inventories and models, and produce peer-reviewed publications and conference presentations. Administrative coordination is a core component, with the prime contractor responsible for managing all subcontractors, overseeing financial and scheduling milestones, consolidating deliverables, and ensuring full compliance with contract terms through a firm fixed-price, all-or-none award. This is a small business set-aside under NAICS code 541715, with a performance period from September 1, 2026, to August 31, 2027, and payment terms of Net 30. All work is centered at NOAA’s Advanced Systems and Modeling Division in Riverdale Park, Maryland, with deliverables due by the end of the period of performance. Quotes must be submitted electronically by August 14, 2026, to the designated NOAA point of contact, and pricing must be provided in accordance with the SF18 form or company letterhead, including monthly and annual breakdowns. The government explicitly states it will not accept responsibility for non-receipt of quotes, and the awardee must confirm receipt. Wage determinations referenced under WD #2015-4265 and WD #2015-4187 apply, and administrative coordination responsibilities—including subcontract management, invoice processing, and final documentation—must be fulfilled by the prime contractor, though technical oversight of scientific tasks remains with NOAA and subcontractors. All contract provisions and clauses are accessible via acquisition.gov, and the solicitation does not require SAM representations that are not included in the official solicitation documents.
Department Of Commerce Noaa

POSTED

about 19 hours ago

DEADLINE

in 9 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Grant
Transformative Technologies for Experimental and Computational RNome Characterization and Functional AnalysisThe NIH Common Fund, in collaboration with multiple NIH Institutes and Centers, is preparing to issue a funding opportunity for the Transformative Technologies initiative under the RNomics program, aimed at developing groundbreaking experimental and computational tools to characterize the full spectrum of RNA molecules in biological systems. This initiative targets high-risk, early-stage innovations that overcome significant limitations in current RNA analysis methods, with a focus on technologies for sequencing RNA, detecting chemical modifications, studying RNA functionality, and analyzing RNA across individual molecules, cells, and tissues. Projects will be structured in two phases, with Phase 1 supporting initial development and proof-of-concept work, and successful proposals eligible for transition to Phase 2, where validated, scalable tools will be delivered for broad community use. The program emphasizes the creation of resources that enable integrated analysis of RNA sequences, structures, modifications, locations, interactions, and functions to deepen understanding of health and disease mechanisms. While applications are not yet being accepted, this forecast notice provides prospective applicants with advance notice to build collaborative teams and refine innovative proposals. The initiative is part of a broader RNomics effort that also includes technology enhancement centers, molecular standards, and a coordinating center, all working toward a unified framework for RNA research. The opportunity is managed by the National Institutes of Health under the Department of Health and Human Services, and inquiries may be directed to the Common Fund RNomics Program at cfrnomics@od.nih.gov. The forecasted posting date for the formal solicitation is August 5, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
RNomics Technology Enhancement CentersThe NIH Common Fund, in partnership with multiple NIH Institutes and Centers, is forecasting the upcoming release of a Notice of Funding Opportunity for the RNomics program, specifically targeting the establishment of RNomics Technology Enhancement Centers (RTECs). These centers will focus on advancing existing RNA-related technologies with proven feasibility to enable integrated, high-resolution analysis of the full RNA landscape—spanning sequences, modifications, structures, locations, interactions, and functions—across diverse cell and tissue types. The goal is to develop robust, community-accessible tools for end-to-end RNA sequencing, precise quantitative mapping of RNA modifications, and comprehensive profiling of RNA dynamics and function, along with novel molecular and biochemical methods for manipulating and functionally testing RNA. RTECs are expected to enhance both experimental and computational platforms, driving measurable improvements in RNA measurement and analysis capabilities that benefit the broader scientific community. The initiative emphasizes scalability, reproducibility, and widespread usability, ensuring that new technologies are not only innovative but also practical for adoption across research settings. Although applications are not currently being accepted, this forecast provides potential applicants with advance notice to build collaborative partnerships and refine competitive proposals. The NIH Common Fund remains the administrative lead, with inquiries directed to cfrnomics@od.nih.gov, and the formal NOFO is anticipated to be posted in August 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 519290
New
Grant
RNomics Outreach and Coordination (ROC) CenterThe NIH Common Fund, in collaboration with multiple NIH Institutes and Centers, is preparing to launch the RNomics program to advance the study of the complete RNA landscape within cells and tissues, encompassing sequences, modifications, structures, locations, interactions, and functions. This initiative aims to generate transformative tools and resources that enable integrated analysis of the RNome to deepen understanding of health and disease. The program will be structured around four components: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. While no applications are currently being accepted, this forecast provides early visibility to allow potential applicants time to build strong collaborations and refine project ideas. The RNomics Outreach and Coordination (ROC) Center will serve as the central hub for the initiative, responsible for managing data infrastructure, promoting community engagement, and ensuring cross-project integration. It will develop a unified data portal, establish and support data standards, coordinate validation and benchmarking of technologies, lead large-scale data analysis efforts, and deliver training and outreach to the scientific community. The ROC Center will also be tasked with planning the long-term sustainability, accessibility, and maintenance of all RNomics data assets. Information for interested parties is available through the designated point of contact at cfrnomics@od.nih.gov, with the official solicitation expected to be released after the forecast posting date of August 5, 2026.
Web Search Portals and All Other Information Services

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)The DISCOVERY study is a multi-center longitudinal effort involving 19 clinical sites dedicated to identifying risk factors and biological mechanisms underlying the development of type 2 diabetes in youth during early puberty. The study is actively recruiting and following high-risk participants over time to understand the progression of the disease, with the Biostatistics Research Center serving as the central coordinating hub responsible for protocol execution, data management, quality control, statistical analysis, and seamless coordination across all participating sites. The center has built a comprehensive infrastructure to ensure data integrity and consistency throughout the prolonged follow-up period. This solicitation seeks to continue support for the existing clinical consortium to achieve its scientific goals, focusing on advancing knowledge of youth-onset type 2 diabetes pathophysiology. The funding opportunity is issued by the National Institutes of Health under the Department of Health and Human Services through a single-source competition, with no set-aside designation. The opportunity is managed by the Division of Diabetes, Endocrinology and Metabolic Diseases, and all correspondence should be directed to niddk_dem@nih.gov. The forecast was posted on August 4, 2026, and no clinical trial is permitted under this award.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Investigator-Focused Award (Parent R35)The National Institutes of Health is preparing to release a Parent R35 Investigator-Focused Award opportunity to support researchers at all career stages, including Early Stage Investigators, through a funding mechanism designed to sustain an entire program of research aligned with the mission of the awarding Institute or Center. Unlike traditional grants that fund specific projects with defined aims, the R35 provides broad, long-term support for an investigator’s scientific vision, enabling them to pursue high-risk, high-reward research without being constrained by narrow project boundaries. This award is intended to be the primary or sole source of research funding from the NIH for the recipient, offering financial stability and the freedom to adapt research directions as new opportunities emerge. The R35 award emphasizes scientific autonomy and reduced administrative burden, allowing recipients to focus more on research, mentoring, and scientific service rather than grant writing and compliance. Key advantages include the ability to follow emerging scientific leads, tackle complex and challenging questions, and foster breakthrough discoveries by encouraging broad, innovative thinking. The award is not restricted by predefined goals, giving investigators maximum flexibility to evolve their research programs over time. The solicitation is published as a forecast with a posted date of July 30, 2026, and all correspondence and inquiries should be directed to the Office of Extramural Research at parentr35@mail.nih.gov.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)The NIH INCLUDE Project is soliciting applications to contribute biospecimens from individuals with Down syndrome and control populations for comprehensive genomic and multi-omics analysis, aiming to uncover the molecular underpinnings of health conditions associated with Down syndrome. This initiative does not provide direct funding to applicants but encourages the submission of existing samples to generate large-scale, integrated data that will be deposited into the INCLUDE Data Hub, making it accessible to the broader scientific community to accelerate research. The focus is on omics phenotypes, with an emphasis on maximizing the scientific value of already collected biospecimens rather than collecting new ones. The opportunity is open to researchers who can align with the goal of generating high-quality, shared data resources and is not eligible for clinical trials. All data generated, including clinical and phenotypic information, will become part of a centralized repository to support collaborative discovery. The notice was posted by the National Institutes of Health under the Department of Health and Human Services, with inquiries directed to the INCLUDE Project email address, and the solicitation is available through the Grants.gov platform. Participation is contingent on the ability to deliver samples and associated metadata to designated NIH-supported resources.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541512
Grant
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)The National Institutes of Health, through the National Cancer Institute, is preparing to issue a funding opportunity aimed at advancing and sustaining high-impact informatics technologies critical to cancer research. This initiative supports tools and software that have moved beyond early-stage prototypes and demonstrate clear potential for broad application across the cancer research continuum, including cancer biology, diagnosis, treatment, early detection, risk assessment, prevention, control, and epidemiology. The program focuses on enhancing, optimizing, and disseminating existing technologies to ensure their long-term usability and adoption by the broader scientific community, with an emphasis on capabilities in data acquisition, management, analysis, visualization, and interpretation. This funding opportunity, designated as U24 and labeled as clinical trial optional, is part of the NCI’s Informatics Technology for Cancer Research Program and is open to organizations capable of scaling proven informatics resources. While no set-aside categories or NAICS codes are specified, interested applicants should note the official point of contact for inquiries is the ITCR Mailbox, reachable via email or phone. The forecasted posting date is July 28, 2026, and all details can be accessed through the Grants.gov portal. The program seeks to ensure that critical digital infrastructure remains robust, adaptable, and accessible to accelerate discoveries and improve outcomes in cancer research.
Computer Systems Design Services

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards ProgramThe National Institutes of Health is forecasting a limited competition for the Institutional Mentored Research Career Development Program under the Clinical and Translational Science Awards Program, aimed at advancing the careers of later-stage postdoctoral fellows and junior faculty dedicated to independent research in clinical and translational science. The program seeks to establish institutional frameworks that provide structured mentoring, training, and research support to ensure timely progression and long-term engagement in transformative health research that bridges laboratory discoveries with real-world patient and public health outcomes. Funding is authorized under Sections 301 and 405 of the Public Health Service Act and governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. Only eligible organizations may apply, and submissions will undergo standard NIH peer review, with awards granted exclusively to meritorious proposals. This funding opportunity is part of the broader Congressionally mandated CTSA initiative designed to build a nationwide network of academic medical centers equipped to accelerate the translation of scientific innovation into clinical and community health improvements. The forecast was posted on July 20, 2026, and inquiries should be directed to the Division of Clinical Innovation at NCATS via the designated email address. All applications must comply with NIH guidelines and are subject to the terms of a limited competition, with no public solicitation beyond the eligible pool of institutions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

17 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant for the Clinical and Translational Science Awards ProgramThe National Institutes of Health, under the Department of Health and Human Services, is forecasting a limited competition for the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant aimed at advancing clinical and translational science. This initiative supports accredited academic medical centers in developing comprehensive training programs for predoctoral and postdoctoral researchers, equipping them with the skills and infrastructure necessary to translate scientific discoveries into effective patient care and public health interventions. The program is aligned with the broader Congressionally mandated Clinical and Translational Science Award (CTSA) initiative, which fosters a national network of institutions dedicated to accelerating the movement of research from laboratory to clinic and community. Funding is authorized under Sections 301 and 405 of the Public Health Service Act and governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. Only eligible organizations invited through the limited competition may submit applications, which will undergo standard NIH peer review to determine merit and funding eligibility. The opportunity is managed by the Division of Clinical Innovation at the National Center for Advancing Translational Sciences, with inquiries directed to a designated point of contact. The forecast was posted on July 20, 2026, and interested parties are encouraged to review eligibility criteria and application guidelines through the official Grants.gov portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

17 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Limited Competition: Research Education Program for the Clinical and Translational Science Awards ProgramThe Congressionally mandated Clinical and Translational Science Award Program aims to accelerate the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health by establishing a national network of academic medical centers equipped with the infrastructure, expertise, training, and collaborative frameworks necessary to bridge laboratory research with clinical and community practice. This forecasted limited competition seeks to support research education activities that complement and strengthen the training of a skilled workforce capable of addressing the nation’s demands in biomedical, behavioral, and clinical research, aligning with the broader goals of the CTSA Program. Awards will be issued under the authority of Sections 301 and 405 of the Public Health Service Act as amended and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Only eligible organizations may apply, and submissions will undergo the National Institutes of Health’s standard peer-review process, with funding reserved for the most meritorious proposals. The opportunity is open to a restricted pool of applicants as defined in the eligibility criteria, with applications to be submitted through the official grants portal, and inquiries should be directed to the Division of Clinical Innovation at NCATS.
Administration of Public Health Programs

POSTED

17 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational ScienceThe Congressionally mandated Clinical and Translational Science Award Program aims to accelerate the translation of scientific discoveries into practical health solutions by funding a national network of academic medical centers that provide the infrastructure, expertise, training, and collaborative environment necessary to move research from the laboratory into clinical practice and community health. Within this program, the High Impact Specialized Innovation Programs are designed to support unique, high-value capabilities, research platforms, or resources that address critical gaps or persistent roadblocks in clinical and translational science at designated CTSA hubs. These initiatives are intended to deliver timely, transformative advances that enhance the overall efficiency and impact of the CTSA network. Awards under this forecast are authorized under Sections 301 and 405 of the Public Health Service Act and governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. This is a limited competition forecast, meaning only pre-eligible organizations may apply, and applications will undergo NIH’s standard peer-review process. Only those deemed meritorious will be considered for funding. The National Institutes of Health, through the Department of Health and Human Services and the Division of Clinical Innovation at NCATS, is soliciting applications with a forecast date of July 20, 2026, and inquiries should be directed to the provided point of contact.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

17 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Clinical and Translational Science AwardThe Congressionally mandated Clinical and Translational Science Award (CTSA) Program aims to strengthen the national infrastructure for accelerating the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health. This initiative funds a network of academic medical centers to provide the essential resources, expertise, training, and collaborative frameworks needed to bridge the gap between laboratory research and clinical practice, as well as community health implementation. The reissuance of the Notice of Funding Opportunity is designed to support a comprehensive CTSA Hub that fosters an integrated environment for research and training in clinical and translational science, while promoting the development, testing, and broad adoption of innovative methods and technologies that increase the efficiency and quality of the entire translational research pipeline. Funding for this program is authorized under Sections 301 and 405 of the Public Health Service Act, as amended, and is governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. The National Institutes of Health, within the Department of Health and Human Services, has issued this forecast to invite eligible organizations to submit applications. Proposals will undergo the NIH’s standard peer-review process, with funding awarded only to those deemed meritorious. The point of contact for inquiries is the Division of Clinical Innovation at NCATS, reachable via the provided email, and all applications must be submitted through the official grants portal listed in the posting.
Administration of Public Health Programs

POSTED

17 days ago

DEADLINE

N/A
View Details